Monogram Technologies insider grant: 40,000 options to CFO Knape
Rhea-AI Filing Summary
Noel Knape, Chief Financial Officer and Director of Monogram Technologies Inc. (MGRM), reported a transaction on Form 4 showing an award of derivative securities. The filing reports that on 01/08/2025 Mr. Knape was granted 40,000 stock options with an exercise price of $2.50. The options have a date exercisable of 01/08/2032 and an expiration date of 01/08/2035, and the underlying security is common stock. The Form identifies Mr. Knape’s address in Austin, TX and is signed by him on 09/30/2025. The filing includes an explanatory note that the company uses the Black-Scholes-Merton model to determine fair value of stock awards.
Positive
- 40,000 stock options granted to CFO/Director Noel Knape (transaction date 01/08/2025)
- Exercise price disclosed at $2.50
- Clear exercisable and expiration dates provided: exercisable 01/08/2032, expiration 01/08/2035
- Form is signed by the reporting person (09/30/2025)
Negative
- None.
Insights
TL;DR: Routine executive option grant of 40,000 options at $2.50, long-dated vesting/exercise period; no other transactions disclosed.
The Form 4 discloses a single derivative award to the CFO and director: 40,000 stock options granted 01/08/2025 with an exercise price of $2.50, exercisable beginning 01/08/2032 and expiring 01/08/2035. This is a disclosure of insider compensation rather than a disposition or sale. The filing also states the company values awards using the Black-Scholes-Merton model. From a reporting perspective the form is complete with reporting person details and signature date.
TL;DR: Governance disclosure shows an officer received a long-dated option award; filing appears standard and properly executed.
The reporting person is identified as both an officer (CFO) and director, and the Form 4 records the grant of 40,000 options. Dates and terms (exercise price $2.50, exercisable 01/08/2032, expiring 01/08/2035) are provided and the form is signed. The explanatory note about Black-Scholes valuation is included. The disclosure is consistent with routine equity-compensation reporting obligations under Section 16.